Werner syndrome cells are sensitive to DNA cross‐linking drugs
2001; Wiley; Volume: 15; Issue: 7 Linguagem: Inglês
10.1096/fj.00-0611fje
ISSN1530-6860
AutoresMartin Poot, Sue S. Yom, Susan H. Whang, Jackson T. Kato, Katherine A. Gollahon, Peter S. Rabinovitch,
Tópico(s)Cell death mechanisms and regulation
ResumoSPECIFIC AIMSTo define the type of chromatin lesion(s) that require the Werner syndrome (WRN) helicase/exonuclease activity to prevent cytotoxicity and S phase prolongation/arrest, we exposed lymph...
Referência(s)